| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/28/2004 | WO2004045520A3 Complement receptor 2 targeted complement modulators |
| 10/28/2004 | WO2004041857A3 Mutant of clostridium difficile toxin b and methods of use |
| 10/28/2004 | WO2004037205A3 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL |
| 10/28/2004 | WO2004035748A3 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 10/28/2004 | WO2004032874A3 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 10/28/2004 | WO2004029274A3 Method for generating an immune response and reagents therefor |
| 10/28/2004 | WO2004029207A3 Optimized fc variants and methods for their generation |
| 10/28/2004 | WO2004024075A3 Chemokine receptor antagonists as therapeutic agents |
| 10/28/2004 | WO2004005349A3 Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures |
| 10/28/2004 | WO2004003157A3 Gene regulation in transgenic animals using a transposon-based vector |
| 10/28/2004 | WO2003104262A3 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 10/28/2004 | WO2003100005A3 Universal chimera bank |
| 10/28/2004 | WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/28/2004 | WO2003087126A3 Heteroclitic analogs and related methods |
| 10/28/2004 | WO2003037371A3 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents |
| 10/28/2004 | WO2003030833A3 Angiopoietin-2 specific binding agents |
| 10/28/2004 | WO2003022882A3 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 10/28/2004 | WO2003020954A3 205p1b5 in treatment and detection of cancer |
| 10/28/2004 | WO2001098460A3 Fusion proteins of mycobacterium tuberculosis |
| 10/28/2004 | WO2001081540A3 Growth factor which acts through erb b-4 rtk |
| 10/28/2004 | US20040214999 Novel compounds for chemiluminescense procedures |
| 10/28/2004 | US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders |
| 10/28/2004 | US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 10/28/2004 | US20040214990 Transmembrane protein differentially expressed in cancer |
| 10/28/2004 | US20040214851 increasing gene expression by contacting with compound comprising imidazoquinoline amine, then contacting with opiod growth factor; pain/scarring reduction |
| 10/28/2004 | US20040214794 perorally or rectally administering an effective amount of a lipopolysaccharide isolated from Escherichia coli |
| 10/28/2004 | US20040214792 Methods of treating inflammation |
| 10/28/2004 | US20040214788 by administering an antagonist against one or more of the vitamin binding proteins riboflavin carrier protein, retinol binding protein, and folic acid binding protein |
| 10/28/2004 | US20040214783 Compositions and methods for treatment of neoplastic disease |
| 10/28/2004 | US20040214768 immunogenic polypeptides containing both self and non-self amino acid segments, used for prophylaxis of sepsis, cardiovascular disorders, adult respiratory distress syndrome, nephritis, graft rejection, arthritis, asthma, inflammatory bowel disease, multiple sclerosis and arteriosclerosis in mammals |
| 10/28/2004 | US20040214764 inhibiting viral replication or infection by contacting a composition with a virally infected cell with a cell impervious cephalin-binding ligand or proteins; treating an animal with a viral infection; hepatitis, influenza, AIDS, viral pneumonia or respiratory disease |
| 10/28/2004 | US20040214761 induction of apoptosis in tumor cells by administering monoclonal antibodies |
| 10/28/2004 | US20040214333 Loading of cells with antigens by electroporation |
| 10/28/2004 | US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines |
| 10/28/2004 | US20040214329 Circular nucleic acid vectors, and methods for making and using the same |
| 10/28/2004 | US20040214327 Nutrient broth comprising transition element ptoyrin complex complex for use in cell propagation |
| 10/28/2004 | US20040214290 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 10/28/2004 | US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 10/28/2004 | US20040214285 HIV-specific fusion proteins and therapeutic and diagnostic methods for use |
| 10/28/2004 | US20040214284 Isolated peptides which bind to MHC class II molecules, and uses thereof |
| 10/28/2004 | US20040214275 Von willebrand factor (vmf)-cleaving enzyme |
| 10/28/2004 | US20040214245 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 10/28/2004 | US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections |
| 10/28/2004 | US20040214225 Immunoglobulin polypeptide for use as diagnostic tool in detecting variable major protein (VMP) of lymes disease; immunodiagnostics and genetic vaccines preventing parasitic infection |
| 10/28/2004 | US20040214208 Enterococcal virulence factors |
| 10/28/2004 | US20040214190 Mammalian c-type lectins |
| 10/28/2004 | US20040214172 Sheeplice, bovicola ovis, allergen treatment |
| 10/28/2004 | US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 10/28/2004 | US20040214159 Carrier of a diamond fine particle for immobilizing virus |
| 10/28/2004 | US20040214158 Treatment of human papillomavirus (hpv)-infected cells |
| 10/28/2004 | US20040213834 Pharmacological preparation made from a nanopatriculate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 10/28/2004 | US20040213817 Killed cells of Mycobacterium avium as immunogens and mineral oil; immunocontraceptive vaccines such as gonadotropin releasing hormone (GnRH) |
| 10/28/2004 | US20040213816 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 10/28/2004 | US20040213809 Method of treating diseases connected with immunity deficiency |
| 10/28/2004 | US20040213808 immunogenic compositions containing as active ingredients recombinantly-produced forms of truncated flavivirus envelope and non-structural glycoproteins; may also include an adjuvant, such as saponin or a saponin-like material |
| 10/28/2004 | US20040213807 Use of Parapox B2L protein to modify immune responses to administered antigens |
| 10/28/2004 | US20040213806 Salmonella typhi vaccine compositions |
| 10/28/2004 | US20040213805 Deletions in arterivirus replicons |
| 10/28/2004 | US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide |
| 10/28/2004 | US20040213803 a polypeptide conjugated to a Streptococcus pneumoniae capsular polysaccharide; an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity; vaccine; genetic vaccine; antigen |
| 10/28/2004 | US20040213802 Gene of novel corynebacterium diphtheriae antigen |
| 10/28/2004 | US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry |
| 10/28/2004 | US20040213800 Active immunization to generate antibodies to soluble A-beta |
| 10/28/2004 | US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors |
| 10/28/2004 | US20040213796 Immunotherapy for chronic myelocytic leukemia |
| 10/28/2004 | US20040213794 Mst1 modulation of apoptosis in cardiac tissue and modultors of Mst1 for treatment and prevention of cardiac disease |
| 10/28/2004 | US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis |
| 10/28/2004 | US20040213791 Monoclonal antibodies; for diagnosis and treatment of prostate cell proliferative disorders; immunogens; immunotherapy; cell lines |
| 10/28/2004 | US20040213785 Stabilizedpreparations containing antibody |
| 10/28/2004 | US20040213784 bone marrow transplant (BMT), peripheral blood stem cell (PBSC); use of anti-CD20 monoclonal antibody (RITUXAN) as a purging agent during treatment of B-cell-related malignancies, e.g., B-cell lymphomas or leukemias; enhance engraftment and/or prevent disease relapse |
| 10/28/2004 | US20040213783 modulation of CD200 or CD200R using a polyclonal antibody; a monoclonal antibody; a humanized antibody; an Fv, Fab, or F(ab')2 fragment; a blocking antibody; or a peptide mimetic of an antibody; autoimmune disorders |
| 10/28/2004 | US20040213782 Compositions of an aquaporin modulating agent and an aqueous humor modulating agent for the treatment of elevated intraocular pressure |
| 10/28/2004 | US20040213779 Methods for treating viral infections using immunoconjugates to aminophospholipids |
| 10/28/2004 | US20040213766 Compositions and methods for treating transplants |
| 10/28/2004 | US20040213761 administering to a patient an effective amount of an agonist or antagonist of IL-23, for wound healing |
| 10/28/2004 | US20040213760 Composition and method for delivery of biologically-active factors |
| 10/28/2004 | US20040213745 Suitable for reconstitution and parenteral administration |
| 10/28/2004 | CA2817265A1 Recombinant il-9 antibodies and uses thereof |
| 10/28/2004 | CA2718356A1 High concentration antibody and protein formulations |
| 10/28/2004 | CA2522985A1 Means and methods for diagnosing and treating affective disorders |
| 10/28/2004 | CA2522238A1 S. pneumoniae antigens |
| 10/28/2004 | CA2522221A1 Immunogen, composition for immunological use, and method of producing a ntibody using the same |
| 10/28/2004 | CA2522082A1 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 10/28/2004 | CA2522007A1 Methods of preventing or treating respiratory conditions |
| 10/28/2004 | CA2521826A1 Recombinant il-9 antibodies and uses thereof |
| 10/28/2004 | CA2521812A1 Optimal polyvalent vaccine for cancer |
| 10/28/2004 | CA2521809A1 Improved heat shock protein-based vaccines and immunotherapies |
| 10/28/2004 | CA2521744A1 Tumor antigens bfa-5 for prevention and/or treatment of cancer |
| 10/28/2004 | CA2521594A1 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 10/28/2004 | CA2521174A1 Enhanced hiv-1 vaccines and methods for their use |
| 10/28/2004 | CA2521109A1 Anti-tumor vasculature effects of human serum albumin derivatives |
| 10/28/2004 | CA2517926A1 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
| 10/28/2004 | CA2517154A1 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 10/28/2004 | CA2463487A1 Tumours treating combinations, compositions and methods |
| 10/27/2004 | EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein |
| 10/27/2004 | EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents |
| 10/27/2004 | EP1471073A2 Hepatitis C virus asialoglycoproteins |
| 10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 10/27/2004 | EP1471035A2 A carrier of a diamond fine particle for immobilizing virus |
| 10/27/2004 | EP1471034A2 Therapeutic calcium phosphate particles and methods of manufacture and use |